Items where authors include "Hamdy, F.C."

Article

Watts, E.L. orcid.org/0000-0001-9229-2589, Gonzales, T.I. orcid.org/0000-0003-0085-8771, Strain, T. et al. (91 more authors) (2024) Observational and genetic associations between cardiorespiratory fitness and cancer: a UK Biobank and international consortia study. British Journal of Cancer, 130 (1). pp. 114-124. ISSN 0007-0920

Bryant, R.J. orcid.org/0000-0002-8330-9251, Yamamoto, H. orcid.org/0000-0003-0831-9174, Eddy, B. et al. (26 more authors) (2023) Protocol for the TRANSLATE prospective, multicentre, randomised clinical trial of prostate biopsy technique. BJU International. ISSN 1464-4096

Lane, J.A., Donovan, J.L., Young, G.J. et al. (26 more authors) (2022) Functional and quality of life outcomes of localised prostate cancer treatments (Prostate Testing for Cancer and Treatment [ProtecT] study). BJU International, 130 (3). pp. 370-380. ISSN 1464-4096

Erickson, A., He, M., Berglund, E. et al. (28 more authors) (2022) Spatially resolved clonal copy number alterations in benign and malignant tissue. Nature, 608 (7922). pp. 360-367. ISSN 0028-0836

Noble, S.M., Garfield, K., Lane, J.A. et al. (24 more authors) (2020) The ProtecT randomised trial cost-effectiveness analysis comparing active monitoring, surgery, or radiotherapy for prostate cancer. British Journal of Cancer, 123 (7). pp. 1063-1070. ISSN 0007-0920

Hamdy, F.C., Donovan, J.L., Lane, J.A. et al. (33 more authors) (2020) Active monitoring, radical prostatectomy and radical radiotherapy in PSA-detected clinically localised prostate cancer : the ProtecT three-arm RCT. Health Technology Assessment, 24 (37). pp. 1-175. ISSN 1366-5278

Neal, D.E., Metcalfe, C., Donovan, J.L. et al. (26 more authors) (2020) Ten-year mortality, disease progression, and treatment-related side effects in men with localised prostate cancer from the ProtecT randomised controlled trial according to treatment received. European Urology, 77 (3). pp. 320-330. ISSN 0302-2838

Wu, X., Scott, H., Carlsson, S.V. et al. (13 more authors) (2019) Increased EZH2 expression in prostate cancer is associated with metastatic recurrence following external beam radiotherapy. The Prostate, 79 (10). pp. 1079-1089. ISSN 0270-4137

Catto, J.W.F. orcid.org/0000-0003-2787-8828, Blazeby, J.M., Holmberg, L. et al. (2 more authors) (2017) In Defense of Randomized Clinical Trials in Surgery: Let Us Not Forget Archie Cochrane's Legacy. European Urology, 71 (5). pp. 820-821. ISSN 0302-2838

Johnston, T.J., Shaw, G.L., Lamb, A.D. et al. (29 more authors) (2017) Mortality Among Men with Advanced Prostate Cancer Excluded from the ProtecT Trial. European Urology, 71 (3). pp. 381-388. ISSN 0302-2838

Lane, A., Metcalfe, C., Young, G.J. et al. (9 more authors) (2016) Patient-reported outcomes in the ProtecT randomized trial of clinically localized prostate cancer treatments: Study design, and baseline urinary, bowel and sexual function and quality of life. BJU International, 118 (6). pp. 869-879. ISSN 1464-4096

Hamdy, F.C., Donovan, J.L., Lane, J.A. et al. (25 more authors) (2016) 10-Year Outcomes after Monitoring, Surgery, or Radiotherapy for Localized Prostate Cancer. New England Journal of Medicine. ISSN 0028-4793

Donovan, J.L., Hamdy, F.C., Lane, J.A. et al. (36 more authors) (2016) Patient-Reported Outcomes after Monitoring, Surgery, or Radiotherapy for Prostate Cancer. New England Journal of Medicine. ISSN 0028-4793

Al Olama, A.A., Benlloch, S., Antoniou, A.C. et al. (65 more authors) (2015) Risk Analysis of Prostate Cancer in PRACTICAL, a Multinational Consortium, Using 25 Known Prostate Cancer Susceptibility Loci. Cancer Epidemiology, Biomarkers and Prevention, 24 (7). pp. 1121-1129. ISSN 1055-9965

Wade, J., Rosario, D.J., Howson, J. et al. (9 more authors) (2015) Role of information in preparing men for transrectal ultrasound guided prostate biopsy: a qualitative study embedded in the ProtecT trial. BMC Health Services Research, 15. 80. ISSN 1472-6963

Drayton, R.M., Rehman, I., Clarke, R. et al. (13 more authors) (2015) Identification and Diagnostic Performance of a Small RNA within the PCA3 and BMCC1 Gene Locus That Potentially Targets mRNA. Cancer Epidemiology, Biomarkers and Prevention, 24 (1). 268 - 275. ISSN 1055-9965

Borkowska, E.M., Kruk, A., Jedrzejczyk, A. et al. (11 more authors) (2014) Molecular subtyping of bladder cancer using Kohonen self-organizing maps. Cancer Medicine, 3 (5). pp. 1225-1234.

Cazier, J.B., Rao, S.R., McLean, C.M. et al. (14 more authors) (2014) Whole-genome sequencing of bladder cancers reveals somatic CDKN1A mutations and clinicopathological associations with mutation burden. Nature Communications, 5. 3756. ISSN 2041-1723

Miah, S., Dudziec, E., Drayton, R.M. et al. (5 more authors) (2012) An evaluation of urinary microRNA reveals a high sensitivity for bladder cancer. British Journal of Cancer, 107 (1). pp. 123-128. ISSN 0007-0920

Rehman, I., Evans, C.A., Glen, A. et al. (9 more authors) (2012) iTRAQ Identification of Candidate Serum Biomarkers Associated with Metastatic Progression of Human Prostate Cancer. PLoS ONE, 7 (2). e30885. ISSN 1932-6203

Bryant, R.J., Pawlowski, T., Catto, J.W.F. orcid.org/0000-0003-2787-8828 et al. (6 more authors) (2012) Changes in circulating microRNA levels associated with prostate cancer. British Journal of Cancer, 106 (4). pp. 768-774. ISSN 0007-0920

Macefield, R.C., Metcalfe, C., Lane, J.A. et al. (8 more authors) (2010) Impact of prostate cancer testing: an evaluation of the emotional consequences of a negative biopsy result. British Journal of Cancer, 102. pp. 1335-1340. ISSN 0007-0920

Tilling, K., Garmo, H., Metcalfe, C. et al. (12 more authors) (2010) Development of a new method for monitoring prostate-specific antigen changes in men with localised prostate cancer: A comparison of observational cohorts. European Urology, 57 (3). pp. 446-452. ISSN 0302-2838

Catto, J.W.F., Abbod, M.F., Wild, P.J. et al. (10 more authors) (2010) The application of artificial intelligence to microarray data: identification of a novel gene signature to identify bladder cancer progression. European Urology, 57 (3). pp. 398-406. ISSN 0302-2838

Lane, J.A., Howson, J., Donovan, J.L. et al. (6 more authors) (2007) Detection of prostate cancer in unselected young men: prospective cohort nested within a randomised controlled trial. BMJ, 335 (7630). pp. 1139-1143. ISSN 0959-8146

Brindle, L.A., Oliver, S.E., Dedman, D. et al. (5 more authors) (2006) Measuring the psychosocial impact of population-based prostate-specific antigen testing for prostate cancer in the UK. BJU International, 98 (4). pp. 777-782. ISSN 1464-4096

Rehman, I., Cross, S.S. orcid.org/0000-0003-2044-1754, Azzouzi, A.R. et al. (7 more authors) (2004) S100A6 (Calcyclin) is a prostate basal cell marker absent in prostate cancer and its precursors. British Journal of Cancer, 91. pp. 739-744. ISSN 0007-0920

Oliver, S.E., Barrass, B., Gunnell, D.J. et al. (7 more authors) (2004) Serum Insulin-Like Growth Factor-I Is Positively Associated With Serum Prostate-Specific Antigen in Middle-Aged Men Without Evidence of Prostate Cancer. Cancer Epidemiology Biomarkers & Prevention, 13 (1). pp. 163-165. ISSN 1055-9965

Oliver, S.E., Gunnell, D., Donovan, J. et al. (7 more authors) (2003) Screen-detected prostate cancer and the insulin-like growth factor axis: results of a population-based case-control study. International Journal of Cancer, 108 (6). pp. 887-892. ISSN 0020-7136

Oliver, S.E., Donovan, J.L., Peters, T.J. et al. (3 more authors) (2003) Recent trends in the use of radical prostatectomy in England: the epidemiology of diffusion. BJU International, 91 (4). pp. 331-336. ISSN 1464-4096

Calvert, N.W., Morgan, A.B., Catto, J.W.F. orcid.org/0000-0003-2787-8828 et al. (4 more authors) (2003) Effectiveness and cost-effectiveness of prognostic markers in prostate cancer. British Journal of Cancer, 88. pp. 31-35. ISSN 0007-0920